Track topics on Twitter Track topics that are important to you
A new study examined whether stereotactic body radiotherapy prior to pembrolizumab improved response rate in lung cancer patients.
Original Article: Can SBRT Improve Immunotherapy Outcomes in Metastatic NSCLC?NEXT ARTICLE
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...